SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $162,102,170 |
| Positions | 52 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| GUARDANT HEALTH INC | GH | COM | $10,127,025 | 67,500 |
| PRAXIS PRECISION MEDICINES I | PRAX | COM NEW | $9,107,962 | 27,205 |
| TG THERAPEUTICS INC | TGTX | COM | $9,060,430 | 164,915 |
| COGENT BIOSCIENCES INC | COGT | COM | $8,147,240 | 210,523 |
| IONIS PHARMACEUTICALS INC | IONS | COM | $6,991,554 | 88,177 |
| ELI LILLY & CO | LLY | COM | $6,587,270 | 5,492 |
| ABIVAX SA | ABVX | SPONSORED ADS | $6,246,962 | 46,878 |
| ALUMIS INC | ALMS | COM | $5,752,323 | 204,418 |
| CYTOKINETICS INC | CYTK | COM NEW | $5,116,171 | 60,056 |
| ENLIVEN THERAPEUTICS INC | ELVN | COM | $5,085,302 | 100,203 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.